Hims & Hers Health, Inc.
HIMS
NYSE·Healthcare·Medical - Care Facilities·Mkt cap $6.2B
$27.52
▼ -1.10%
P/E
-43.91
Mkt Cap
$6.2B
52-Wk Range
$13.74–$65.30
52-Week Range
$13.74 - $65.30
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 42.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
6 reasons
- Integrated telehealth platform with licensed provider network reducing access barriers
- Direct-to-consumer model enabling higher margins and customer data insights
- Diversified product portfolio across wellness categories driving cross-selling opportunities
- Brand recognition in digital health with strong millennial and Gen Z adoption
- Proprietary technology platform and mobile app creating switching costs
- Recurring revenue model through prescription refills and subscription services
Bear Case
1 risk
- High volatility (beta 2.4). Larger-than-normal price swings expected.
Growth
Moderate growth ahead
Expanding telehealth adoption and normalization of virtual healthcare consultations
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
-0.7% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying HIMS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 10, 2026
Reported EPS of -$0.37 vs -$0.05 consensus (-643.1% surprise). Revenue of $753.2M vs $698.9M expected (+7.8%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-643.1%
Revenue trend · last 8Q
—
+95%
+111%
+73%
+49%
+28%
+4%
+38%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$401.6M
$481.1M
$586.0M
$544.8M
$599.0M
$617.8M
$608.1M
$753.2M
Margins · last 8Q
Gross
76.7%
Operating
-12.9%
Profit
-11.5%
Wall Street consensus
13 analysts · 31% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
31%
Hold
69%
Sell
0%
Median Price Target
—
Latest: KeyBanc · Sep 2, 2026
vs Industry
How HIMS stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related